Insulet (PODD) earnings

Earnings (net income) · fiscal 2025
$247.10M

Insulet (PODD) reported net income of $247.10M in fiscal 2025 (the year ended December 31, 2025). That is 40.9% lower than the $418.30M of fiscal 2024. Figures as of 18 Nov 2026, 04:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$247.10M
Change on fiscal 2024
−40.9%
Growth, 5 years
+105.2% a year
Highest on record
$418.30Mfiscal 2024
Lowest on record
-$73.52Mfiscal 2015
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Insulet earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 105.2% a year. Across the 17 fiscal years on record (2009–2025), the highest was $418.30M in fiscal 2024 and the lowest -$73.52M in fiscal 2015.

History · 17 fiscal years

Earnings (net income) by fiscal year

Insulet earnings, year by year

Insulet (PODD) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$247.10M 40.9% down
2024$418.30M 102.8% up
2023$206.30M 4,384.8% up
2022$4.60M 72.6% down
2021$16.80M 147.1% up
2020$6.80M 41.4% down
2019$11.60M 251.5% up
2018$3.30M—
2017-$26.80M—
2016-$28.88M—
2015-$73.52M—
2014-$51.50M—
2013-$44.97M—
2012-$51.87M—
2011-$45.83M—
2010-$61.16M—
2009-$72.34M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Insulet and comparable companies
CompanyEarnings (net income)Fiscal year
Vaxcyte PCVX-$766.63M2025
Bio-Rad Laboratories BIO$759.90M2025
Molina Healthcare MOH$472.00M2025
Spyre Therapeutics SYRE-$155.20M2025
Qiagen QGEN$424.88M2025
Insulet PODD$247.10M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet earnings: questions and answers

What is Insulet's net income?

Insulet (PODD) reported net income of $247.10M in fiscal 2025 (the year ended December 31, 2025). That is 40.9% lower than the $418.30M of fiscal 2024.

What is the growth rate of Insulet's net income?

Over the five fiscal years to 2025 net income grew at a compound 105.2% a year.

What are the highest and lowest net income figures on record for Insulet?

Across the 17 fiscal years on record (2009–2025), the highest was $418.30M in fiscal 2024 and the lowest -$73.52M in fiscal 2015.

How is Insulet's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/PODD/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.